Profile
Elizabeth Alcamo is an Entrepreneur-in-Residence at Versant Venture Management LLC.
She previously worked as a Director at Adverum Biotechnologies, Inc. from 2014 to 2016, as a Senior Director at 4D Molecular Therapeutics, Inc. from 2016 to 2017, and as a Vice President at CODA Biotherapeutics, Inc. from 2018 to 2019.
Ms. Alcamo holds a doctorate degree from Massachusetts Institute of Technology, which she obtained in 2000, and an undergraduate degree from Williams College, which she obtained in 1990.
Elizabeth Alcamo active positions
| Companies | Position | Start |
|---|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Private Equity Investor | 30/09/2020 |
Former positions of Elizabeth Alcamo
| Companies | Position | End |
|---|---|---|
CODA Biotherapeutics, Inc.
CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology Develops chemo genetic neuromodulation platform for the treatment of severe neurological disorders | Corporate Officer/Principal | 30/04/2019 |
| 4D MOLECULAR THERAPEUTICS, INC. | Corporate Officer/Principal | 31/05/2017 |
| ADVERUM BIOTECHNOLOGIES, INC. | Corporate Officer/Principal | 31/03/2016 |
Training of Elizabeth Alcamo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Williams College
Williams College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
CODA Biotherapeutics, Inc.
CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology Develops chemo genetic neuromodulation platform for the treatment of severe neurological disorders | Health Technology |
- Stock Market
- Insiders
- Elizabeth Alcamo
















